From October 1, 2023 to November 17, 2023, the company has repurchased 10,554,961 shares, representing 2.25% for CNY 387.19 million. With this, the company has completed the repurchase of 27,164,101 shares, representing 5.77% for CNY 1,000 million under the buyback announced on August 29, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
43.79 CNY | -2.56% | +7.83% | +16.25% |
05-09 | Andon Health's Subsidiary Gets US FDA's Nod to Market COVID-19, Influenza Test Kit | MT |
05-08 | Andon Health's US Unit Gets FDA Emergency Use Authorization for 3-in-1 Home Test Kits | MT |
1st Jan change | Capi. | |
---|---|---|
+16.25% | 2.8B | |
-1.48% | 8.37B | |
+10.15% | 5.84B | |
+25.61% | 5.4B | |
-4.58% | 4.37B | |
-51.80% | 3.23B | |
+30.25% | 2.26B | |
-7.81% | 2.22B | |
-4.08% | 1.87B | |
+3.02% | 1.6B |
- Stock Market
- Equities
- 002432 Stock
- News Andon Health Co., Ltd.
- Tranche Update on Andon Health Co., Ltd.'s Equity Buyback Plan announced on August 29, 2023.